Let’s End Cancer-Related Lymphedema Through Prevention
Help Prevent Cancer-Related Lymphedema with a 30-second Test
SOZO® with L-Dex® delivers a precise fluid measurement reading quickly at the point of care. With periodic testing following cancer treatment, high-risk patients may be placed on a compression treatment protocol at the earliest possible stage to prevent the condition from progressing.
Help Cancer Survivors Avoid Chronic Secondary Lymphedema
Introduce lymphedema prevention protocol immediately upon cancer diagnosis to prevent lymphedema progression and improve quality of life in cancer survivors.
Provide more effective lymphedema treatment solutions for patients in the subclinical and stage 1 levels of lymphedema.
Get reliable, accurate noninvasive fluid measurement results in about 30 seconds using SOZO® with L-Dex®.
Detect Lymphedema Early and Intervene to Avoid Progression
Accurately Measure & Monitor Patient Fluid Status with L-Dex
SOZO® incorporates L-Dex® technology and bioimpedance spectroscopy (BIS) to quickly and easily provide an accurate measurement of fluid status – the L-Dex score. The L-Dex score represents the difference in the amount of extracellular fluid in an at-risk limb compared to an unaffected limb.
Capture & Share a Patient L-Dex® Score in Seconds
SOZO® allows medical staff in hospitals and cancer clinics to test patients at any location and immediately share that information with surgeons, oncologists, nurse practitioners, therapists and other members of the care team.
Compression Garments Help Control Lymphedema Progression
L-Dex® Testing Paired with Compression Therapy Can Reduce Lymphedema Progression
Clinical data shows that prescribed compression therapy combined with periodic L-Dex® testing has been shown to reduce the progression of lymphedema by 95% in breast cancer patients1.
Guidelines for Lymphedema Prevention
A Lymphedema Prevention Program Gives Hope to Cancer Patients
Test Upon Diagnosis & Periodically after Cancer Surgery
Once a patient has been diagnosed with breast cancer, melanoma, or pelvic area cancers, they will be tested by a member of your staff to record a baseline L-Dex® score. The test itself takes less than 30 seconds and provides an immediate reading. After cancer surgery, patients should get tested every 3 months for the first 3 years, every 6 months for years 4 and 5, and annually thereafter2.
Evaluate Elevated L-Dex® Readings above the Baseline
Evidence shows that if a patient’s L-Dex® score increases 6.5 or more from the baseline, that’s a “trigger” to evaluate the patient and initiate intervention1.
Apply Treatment to Reduce Lymphedema Progression
Treatment for patients diagnosed with early lymphedema, including standard compression garments worn at home for 4 weeks, 12 hours per day, has been shown to reduce the progression of lymphedema by 95% in breast cancer patients1.
Recommend a Lymphedema Prevention Program for Your Cancer Clinic or Private Practice
ImpediMed has created a step-by-step playbook for lymphedema prevention to help caregivers administer the SOZO® test and to escalate treatment if the L-Dex® score indicates lymphedema may be developing. Download our guide to learn more about the advantages of adding a lymphedema prevention program.
Together, We Can End Cancer-Related Lymphedema
Contact us to learn about SOZO® with L-Dex® and the benefits of supporting a Lymphedema Prevention Program.
- Ridner SH, et al. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis. Ann Surg Oncol 2019; https://doi.org/10.1245/s10434-019-07344-5.
- Shah C, et al. Bioimpedance Spectroscopy for Breast Cancer Related Lymphedema Assessment: Clinical Practice Guidelines. The Breast Journal 2016;DOI: 10.1111/tbj.12647.
General or Sales Inquiries
5900 Pasteur Ct.
Carlsbad, CA 92008 USA
+1-877-247-0111 (Toll Free)
50 Parker Court
Pinkenba, QLD 4008 Australia
Phone: + 61-7-3860-3700
Fax: + 61-7-3260-1225
Free call: 1-800-638-477